Stocks
Aethlon Medical, Inc.AEMD
NASDAQHealthcareMedical Devices$5.05
Price as of · delayed, not real-time
A development-stage medical device company focused on therapeutic apheresis, primarily targeting cancer and infectious diseases. Its lead product, the Aethlon Hemopurifier, is designed to remove circulating viruses and exosomes from blood. Investors track AEMD for its clinical trial progress and regulatory milestones.
52W Range: $1.41-$29.45
Congressional Interest in Aethlon Medical, Inc. (AEMD)
No congressional trades have been disclosed for Aethlon Medical, Inc. (AEMD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AEMD?
No congressional trades found for this stock.